Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Flatulex" (23)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Silicones (A03AX13) 7 products
WHO-DDD
DrugBank.ca
IP
CI
Flatulex
-
T
50 Tablet(s)
4.80
8.85
10 %
Chewing tablets: 2 Active Agents
Bayer (Schweiz) AG
●
D / SL
FB
G
IP
CI
Flatulex
50 ml
4.89
9.05
10 %
Tropfen zum Einnehmen: Simeticonum 41.2 mg/ml
Bayer (Schweiz) AG
D / SL
FB
G
CI
Hübner Silicea Balsam
200 ml
11.00
k.A.
Fluid: Silica Colloidalis Anhydrica
Dermapharm AG
D
FB
G
CI
Hübner Silicea Balsam
15 x 15 ml
k.A.
Fluid: Silica Colloidalis Anhydrica
Dermapharm AG
D
FB
G
CI
Hübner Silicea Balsam
30 x 15 ml
k.A.
Fluid: Silica Colloidalis Anhydrica
Dermapharm AG
D
FB
G
CI
Hübner Silicea Balsam
500 ml
23.20
k.A.
Fluid: Silica Colloidalis Anhydrica
Dermapharm AG
D
FB
G
Simet-AF Tropfen (aH)
30 ml
k.A.
Suspension: Simethiconum 69 mg
Somapharm AG
D
FB
G
Cardiovascular System (C) 16 products
WHO-DDD
IP
CI
Olanzapin Spirig HC 5
28 Tablet(s)
32.73
52.00
10 %
Coated tablets: Olanzapinum 5 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
IP
CI
Flatulex
-
T
50 Tablet(s)
4.80
8.85
10 %
Chewing tablets: 2 Active Agents
Bayer (Schweiz) AG
●
D / SL
FB
G
L
IP
Ultomiris 300 mg/30 ml
4035.23
4181.20
10 %
Concentrate for infusion: Ravulizumabum 300mg / 30ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Ultomiris 300 mg/3 ml
4035.23
4181.20
10 %
Concentrate for infusion: Ravulizumabum 300mg / 3ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Ultomiris 1100 mg/11 ml
14795.84
15221.60
10 %
Concentrate for infusion: Ravulizumabum 1100mg / 11ml
Alexion Pharma GmbH
A / SL
FB
G
L
IP
Idefirix 11 mg
+ +
137798.05
141688.60
10 %
poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg
iQone Healthcare
Switzerland SA
A / SL
FB
G
IP
CI
Tiberal 1 g/6 mL
5 ampoule(s)
k.A.
Concentrate for infusion: Ornidazolum
Curatis AG
B
FB
G
IP
CI
Crysalis Leman
30 g
k.A.
Gel: 2 Active Agents
Leman SKL SA
B
FB
G
IP
CI
Crysalis Leman
60 g
k.A.
Gel: 2 Active Agents
Leman SKL SA
B
FB
G
IP
CI
Crysalis Leman
2 x 60 g
k.A.
Gel: 2 Active Agents
Leman SKL SA
B
FB
G
IP
CI
Diclo-Acino 10 mg/g
50 g
k.A.
Gel: Diclofenacum Natricum 10 mg
Acino Pharma AG
D
FB
G
IP
CI
Diclo-Acino 10 mg/g
100 g
k.A.
Gel: Diclofenacum Natricum 10 mg
Acino Pharma AG
D
FB
G
IP
CI
Ayvakyt 25 mg
30
k.A.
Coated tablets: Avapritinibum 25 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 100 mg
30
k.A.
Coated tablets: Avapritinibum 100 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
CI
Ayvakyt 300 mg
30
k.A.
Coated tablets: Avapritinibum 300 mg
Blueprint Medicines
(Switzerland) GmbH
A
FB
G
IP
Idefirix 11 mg
2
k.A.
poudre pour solution à diluer pour perfusion: Imlifidasum 11 mg
iQone Healthcare
Switzerland SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
